Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.

Menge T, Lalive PH, von Büdingen HC, Genain CP.

J Neuroinflammation. 2011 Nov 17;8:161. doi: 10.1186/1742-2094-8-161.

2.

Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.

Nakashima I, Takahashi T, Cree BA, Kim HJ, Suzuki C, Genain CP, Vincent T, Fujihara K, Itoyama Y, Bar-Or A.

J Clin Neurosci. 2011 Jul;18(7):997-8. doi: 10.1016/j.jocn.2010.12.011. Epub 2011 May 11.

PMID:
21565508
3.

Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.

Menge T, von Büdingen HC, Lalive PH, Genain CP.

Eur J Immunol. 2007 Nov;37(11):3229-39.

4.

Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity.

Gardell JL, Dazin P, Islar J, Menge T, Genain CP, Lalive PH.

J Clin Virol. 2006 Dec;37 Suppl 1:S11-6.

PMID:
17276360
5.

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays.

Lalive PH, Menge T, Barman I, Cree BA, Genain CP.

Neurology. 2006 Jul 11;67(1):176-7. No abstract available.

PMID:
16832107
6.

Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.

von Büdingen HC, Menge T, Hauser SL, Genain CP.

Immunogenetics. 2006 Apr;58(2-3):122-8. Epub 2006 Mar 10.

PMID:
16528499
7.

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Lalive PH, Menge T, Delarasse C, Della Gaspera B, Pham-Dinh D, Villoslada P, von Büdingen HC, Genain CP.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2280-5. Epub 2006 Feb 3.

8.

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

Menge T, Lalive PH, von Büdingen HC, Cree B, Hauser SL, Genain CP.

J Allergy Clin Immunol. 2005 Aug;116(2):453-9.

PMID:
16083805
9.

Poly(ADP-ribose) polymerase-1 activation in a primate model of multiple sclerosis.

Kauppinen TM, Suh SW, Genain CP, Swanson RA.

J Neurosci Res. 2005 Jul 15;81(2):190-8.

PMID:
15931673
10.
11.

Role of nerve growth factor and other trophic factors in brain inflammation.

Villoslada P, Genain CP.

Prog Brain Res. 2004;146:403-14. Review.

PMID:
14699976
12.

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.

Robinson WH, Fontoura P, Lee BJ, de Vegvar HE, Tom J, Pedotti R, DiGennaro CD, Mitchell DJ, Fong D, Ho PP, Ruiz PJ, Maverakis E, Stevens DB, Bernard CC, Martin R, Kuchroo VK, van Noort JM, Genain CP, Amor S, Olsson T, Utz PJ, Garren H, Steinman L.

Nat Biotechnol. 2003 Sep;21(9):1033-9. Epub 2003 Aug 10.

PMID:
12910246
13.

Approved and future pharmacotherapy for multiple sclerosis.

Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS.

Neurologist. 2002 Sep;8(5):290-301.

PMID:
12803676
14.

Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination.

von Büdingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP.

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8207-12.

15.

The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study.

Koehler NK, Genain CP, Giesser B, Hauser SL.

J Immunol. 2002 Jun 1;168(11):5920-7.

16.

Activity of a newly identified serine protease in CNS demyelination.

Scarisbrick IA, Blaber SI, Lucchinetti CF, Genain CP, Blaber M, Rodriguez M.

Brain. 2002 Jun;125(Pt 6):1283-96.

PMID:
12023317
17.

Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein.

Mesleh MF, Belmar N, Lu CW, Krishnan VV, Maxwell RS, Genain CP, Cosman M.

Neurobiol Dis. 2002 Mar;9(2):160-72.

PMID:
11895369
18.

Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.

Genain CP, Hauser SL.

Immunol Rev. 2001 Oct;183:159-72. Review.

PMID:
11782255
19.

Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus.

von Büdingen HC, Hauser SL, Nabavi CB, Genain CP.

Immunogenetics. 2001 Sep;53(7):557-63.

PMID:
11685468
20.

Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates.

Villoslada P, Abel K, Heald N, Goertsches R, Hauser SL, Genain CP.

Eur J Immunol. 2001 Oct;31(10):2942-50.

21.

Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules.

Villinger F, Bostik P, Mayne A, King CL, Genain CP, Weiss WR, Ansari AA.

Immunogenetics. 2001 May-Jun;53(4):315-28.

PMID:
11491535
22.

Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis.

Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP.

Arch Neurol. 2001 Jul;58(7):1081-6.

PMID:
11448297
23.

Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

von Büdingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, Genain CP.

J Clin Immunol. 2001 May;21(3):155-70. Review.

PMID:
11403222
24.

Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis.

Uccelli A, Giunti D, Mancardi G, Caroli F, Fiorone M, Seri M, Hauser SL, Genain CP.

Eur J Immunol. 2001 Feb;31(2):474-9.

25.

Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis.

McFarland HI, Lobito AA, Johnson MM, Palardy GR, Yee CS, Jordan EK, Frank JA, Tresser N, Genain CP, Mueller JP, Matis LA, Lenardo MJ.

J Immunol. 2001 Feb 1;166(3):2116-21.

26.

Specific immunotherapy: one size does not fit all.

Genain CP, Zamvil SS.

Nat Med. 2000 Oct;6(10):1098-100. No abstract available.

PMID:
11017135
27.

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.

Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP.

J Exp Med. 2000 May 15;191(10):1799-806.

28.

Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.

Diaz-Villoslada P, Shih A, Shao L, Genain CP, Hauser SL.

J Neuroimmunol. 1999 Sep 1;99(1):36-43.

PMID:
10496175
29.

MR imaging investigations in a non-human primate model of multiple sclerosis.

Genain CP.

AJNR Am J Neuroradiol. 1999 Jun-Jul;20(6):955-7. Review. No abstract available.

30.
31.

Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.

McFarland HI, Lobito AA, Johnson MM, Nyswaner JT, Frank JA, Palardy GR, Tresser N, Genain CP, Mueller JP, Matis LA, Lenardo MJ.

J Immunol. 1999 Feb 15;162(4):2384-90.

32.

Identification of autoantibodies associated with myelin damage in multiple sclerosis.

Genain CP, Cannella B, Hauser SL, Raine CS.

Nat Med. 1999 Feb;5(2):170-5.

PMID:
9930864
33.

Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein.

Genain CP, Gritz L, Joshi N, Panicali D, Davis RL, Whitaker JN, Letvin NL, Hauser SL.

J Neuroimmunol. 1997 Nov;79(2):119-28.

PMID:
9394784
34.

Creation of a model for multiple sclerosis in Callithrix jacchus marmosets.

Genain CP, Hauser SL.

J Mol Med (Berl). 1997 Mar;75(3):187-97. Review.

PMID:
9106075
35.

Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus.

Uccelli A, Oksenberg JR, Jeong MC, Genain CP, Rombos T, Jaeger EE, Giunti D, Lanchbury JS, Hauser SL.

J Immunol. 1997 Feb 1;158(3):1201-7.

PMID:
9013960
36.

Late complications of immune deviation therapy in a nonhuman primate.

Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL.

Science. 1996 Dec 20;274(5295):2054-7.

PMID:
8953031
37.
38.

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL.

J Clin Invest. 1995 Dec;96(6):2966-74.

39.

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.

Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL.

Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3601-5.

40.

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.

Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL.

Ann Neurol. 1995 Apr;37(4):519-30.

PMID:
7717689
41.

In healthy primates, circulating autoreactive T cells mediate autoimmune disease.

Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL.

J Clin Invest. 1994 Sep;94(3):1339-45.

43.

Failure of salt loading to inhibit tissue norepinephrine turnover in prehypertensive Dahl salt-sensitive rats.

Genain CP, Reddy SR, Ott CE, Van Loon GR, Kotchen TA.

Hypertension. 1988 Dec;12(6):568-73.

PMID:
3203961
44.
45.

Aortic input impedance in normal man and arterial hypertension: its modification during changes in aortic pressure.

Merillon JP, Fontenier GJ, Lerallut JF, Jaffrin MY, Motte GA, Genain CP, Gourgon RR.

Cardiovasc Res. 1982 Nov;16(11):646-56.

PMID:
7168841

Supplemental Content

Loading ...
Support Center